Education
About Us
Working with TipRanks
Follow Us
Integra Lifesciences Holdings Corp. (IART)
NASDAQ:IART
Earnings Data
Report Date
Apr 23, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
0.43Last Year’s EPS
0.55Same Quarter Last Year
Based on 6 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Feb 25, 2025
|% Change Since: 4.31%
|Next Earnings Date:Apr 23, 2025
Earnings Call Sentiment|Neutral
The earnings call highlighted strong revenue growth and EPS performance. However, significant operational challenges and quality-related issues impacted organic growth and margins. The company is focused on executing its compliance master plan and improving manufacturing capacity. Guidance for the first quarter of 2025 indicates potential continued challenges, but strategic initiatives show promise for future growth.Company Guidance
In the Integra LifeSciences Fourth Quarter 2024 Earnings Conference Call, the company announced a total revenue of $443 million for the quarter, representing an 11.5% year-over-year increase, landing within their guidance range. The adjusted EPS for the quarter was $0.97, surpassing the guidance range. The full-year 2024 revenues were reported at $1.61 billion, indicating a 4.5% growth on a reported basis but a 1.3% decline organically due to supply challenges. For 2025, first-quarter revenues are forecasted between $375 million and $385 million, with expected organic growth ranging from negative 6.2% to negative 3.5%. Full-year 2025 revenues are projected to be between $1.65 billion and $1.72 billion, with an anticipated adjusted EPS of $2.41 to $2.51. The guidance includes potential impacts from quality-related shipping holds, reflecting a cautious outlook amidst ongoing operational improvements.Revenue Growth
Total revenue for the fourth quarter was $443 million, representing year-over-year reported growth of 11.5% within the guidance range. This increase was driven by supply chain recovery, clearance of ship holds, and the ramp-up of Integra Skin production.
Adjusted EPS Performance
Fourth quarter adjusted EPS was $0.97, which was above the guidance range, supported by a sequential increase in revenue and successful integration of Acclarent.
CSS Revenue Highlights
Reported fourth quarter revenues in CSS were $314.7 million, an increase of 15.8% on a reported basis and 4.1% on an organic basis, driven by the Acclarent acquisition and strong performance in the neurosurgery segment.
Tissue Technologies Growth
Tissue Technologies grew 2% on both a reported and organic basis compared to the prior year, with Wound Reconstruction franchise sales increasing by 8.2%.
Strategic Initiatives
The company is advancing its dual PMA clinical strategy for SurgiMend and DuraSorb to capitalize on the implant-based breast reconstruction market and expanded its international commercial footprint in Brazil, India, Korea, and China.
---
IART Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
IART Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Feb 25, 2025 | $22.05 | $24.72 | +12.11% |
| Nov 04, 2024 | $19.28 | $24.12 | +25.10% |
| Jul 29, 2024 | $31.43 | $25.42 | -19.12% |
| May 06, 2024 | $28.89 | $23.14 | -19.90% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Integra Lifesciences Holdings Corp. (IART) report earnings?
Integra Lifesciences Holdings Corp. (IART) is schdueled to report earning on Apr 23, 2025, TBA Not Confirmed.
What is Integra Lifesciences Holdings Corp. (IART) earnings time?
Integra Lifesciences Holdings Corp. (IART) earnings time is at Apr 23, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is IART EPS forecast?
IART EPS forecast for the fiscal quarter 2025 (Q1) is 0.43.
---